Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study (2021)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2021-147733
- Subjects: CICLOSPORINAS; ANEMIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Conference titles: ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
VALLEJO, Carlos et al. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147733. Acesso em: 02 nov. 2025. , 2021 -
APA
Vallejo, C., Jang, J. H., Finelli, C., Montaño Figueroa, E., Norasetthada, L., Calado, R. T., et al. (2021). Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147733 -
NLM
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1182/blood-2021-147733 -
Vancouver
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1182/blood-2021-147733 - Variações da qPCR e seus usos
- Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia
- Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia
- Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas
- U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival
- The future of aplastic anemia treatment in Brazil: lessons learned for global hematology
- Targeting complement to treat paroxysmal nocturnal hemoglobinuria (PNH)
- Telomere dynamics in mice and humans
- A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome
- Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia
Informações sobre o DOI: 10.1182/blood-2021-147733 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003232353.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
